Patient Preference and Adherence (Sep 2022)
Risk Factors for Suboptimal Adherence Identified by Patient-Reported Outcomes Assessments in Routine HIV Care at 2 North American Clinics
Abstract
Duncan Short,1 Xueqi Wang,2 Shivali Suri,3 Thomas K Hsu,2 Bryn Jones,1 Rob J Fredericksen,4 Heidi M Crane,4 Alexandra Musten,5 Jean Bacon,5 Yongwei Wang,2 Kevin A Gough,3 Moti Ramgopal,6 Jeff Berry,7 William B Lober4 1ViiV Healthcare, Brentford, UK; 2ViiV Healthcare, Durham, NC, USA; 3St Michael’s Hospital, Toronto, ON, Canada; 4Center for AIDS Research, University of Washington, Seattle, WA, USA; 5Ontario HIV Treatment Network, Toronto, ON, Canada; 6Midway Specialty Care Center, Fort Pierce, FL, USA; 7TPAN, Chicago, IL, USACorrespondence: Duncan Short, ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK, Tel +44 7827 282971, Email [email protected]: Use of patient-reported outcomes assessments (PROs) can improve patient–provider communication and focus provider attention on current health issues. This analysis examines the association between suboptimal antiretroviral therapy (ART) adherence and factors obtained through PROs among people with HIV (PWH) at 2 North American outpatient clinics.Patients and Methods: Immediately before a clinic visit, PWH completed self-administered PROs. Unadjusted and adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated from logistic regression models to identify sociodemographic and health-related factors (satisfaction with ART, difficulty meeting housing costs, depression, intimate partner violence, risk of malnutrition, smoking status, alcohol use, and substance use) associated with suboptimal adherence (defined as self-reporting < 95% or < 80% adherence). Multiple imputation was performed to account for missing data in the multivariate analyses.Results: Of 1632 PWH, 1239 (76%) responded to the adherence assessment; of these, 268 (22%) and 106 (9%) reported < 95% and < 80% adherence, respectively. Of 1580 PWH who responded, 354 (22%) were dissatisfied with their HIV medication. Of responding PWH, 19% reported moderate-to-severe depression, 23% indicated they were at risk of malnutrition, 34% were current smokers, and 62% reported substance use in the past 3 months. Dissatisfaction with ART was significantly associated with < 95% and < 80% adherence in the unadjusted analysis (unadjusted OR [95% CI], 3.38 [2.51– 4.56] and 4.26 [2.82– 6.42], respectively) and adjusted analysis (adjusted OR [95% CI], 2.76 [1.91– 4.00] and 3.28 [1.95– 5.52], respectively); significance remained after multiple imputation. In adjusted analyses, no risk of malnutrition was significantly associated with reduced odds of < 95% adherence after multiple imputation (adjusted OR [95% CI], 0.714 [0.511– 0.997]); no other factors were associated with < 95% or < 80% adherence.Conclusion: These results suggest that implementation of PROs evaluating treatment satisfaction may provide value to adherence management in routine HIV care.Keywords: patient satisfaction, antiretroviral therapy, highly active, treatment adherence, implementation science, quality of life